Medical Facilities Corporation
MFCSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.12 | -0.20 | 0.20 |
| FCF Yield | 29.51% | 33.34% | 29.03% | 29.37% |
| EV / EBITDA | 2.71 | 3.37 | 6.52 | 2.99 |
| Quality | ||||
| ROIC | 24.76% | 19.10% | 10.61% | 18.58% |
| Gross Margin | 66.32% | 36.50% | 66.10% | 67.38% |
| Cash Conversion Ratio | 0.79 | 3.86 | 4.64 | 1.63 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.91% | 3.78% | 5.28% | 0.04% |
| Free Cash Flow Growth | 34.51% | 12.66% | -25.18% | -15.52% |
| Safety | ||||
| Net Debt / EBITDA | -0.42 | 1.19 | 2.51 | 0.77 |
| Interest Coverage | 13.82 | 4.07 | 3.64 | 12.71 |
| Efficiency | ||||
| Inventory Turnover | 19.24 | 31.41 | 15.60 | 12.21 |
| Cash Conversion Cycle | 13.71 | 38.80 | 11.98 | 18.95 |